ORG 9731
Latest Information Update: 14 Feb 1996
Price :
$50 *
At a glance
- Originator Organon
- Class Cardiotonics; Hydroxamic acids; Small molecules; Thiophenes
- Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 14 Feb 1996 Discontinued-II for Heart failure in Germany (Unknown route)
- 14 Jun 1995 New profile
- 14 Jun 1995 No-Development-Reported for Heart failure in Germany (Unknown route)